Evaluation of Biosimilar Utilization by Hospital Types

In The News,

Sep 19 2022

Evaluation of Biosimilar Utilization by Hospital Types

Worked with a pharmaceutical trade organization to identify biosimilars of interest. Biosimilars and their reference products’ utilization were totaled for each hospital by year. Analyses examined the interaction of market entry of the biosimilars, hospitals’ 340B status, teaching status, and other variables.

Interested in hearing more from us?

Receive customized email alerts from the ADVI team